- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Palbociclib, as a CDK4/6 inhibitor, commonly has side effects including hematological toxicity, gastrointestinal reactions, and fatigue, which ...
Gefitinib is an EGFR tyrosine kinase inhibitor primarily used for the treatment of EGFR mutation positive non-small cell lung cancer. Its con...
Gefitinib, as an EGFR-TKI inhibitor, is contraindicated in patients with specific genotypes, pregnancy, and organ dysfunction, while also payin...
Neratinib is an oral tyrosine kinase inhibitor, which is mainly used for adjuvant treatment and advanced treatment of HER2 positive breast canc...
As an anti-tumor drug, the side effects of Neratinib involve digestive system, skin reactions, and systemic symptoms, which require targeted ...
The contraindications for Tazemetostat mainly involve specific populations and drug interactions, and medication for special populations needs ...
The contraindications of Tazemetostat involve specific populations, dietary interactions, and treatment restrictions, and must be strictly foll...
Tazemetostat is an EZH2 methyltransferase inhibitor primarily used to treat tumors with specific gene mutations. Its indications include epithe...
Tazemetostat, as an EZH2 methyltransferase inhibitor, commonly has side effects involving hematological toxicity, gastrointestinal reactions, a...
Pazopanib is a multi-target tyrosine kinase inhibitor primarily used for the treatment of advanced renal cell carcinoma and soft tissue sarcoma...
